Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
20.02
-0.23 (-1.14%)
At close: Mar 5, 2026, 4:00 PM EST
20.08
+0.06 (0.30%)
After-hours: Mar 5, 2026, 6:58 PM EST
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Sabra Health Care REIT stock have an average target of 21.75, with a low estimate of 21 and a high estimate of 24. The average target predicts an increase of 8.64% from the current stock price of 20.02.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sabra Health Care REIT stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 5 | 6 | 6 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 8 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | +4.90% | Mar 2, 2026 |
| UBS | UBS | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | +4.90% | Feb 19, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $21 → $24 | Strong Buy | Maintains | $21 → $24 | +19.88% | Feb 18, 2026 |
| Citizens | Citizens | Buy Maintains $22 → $23 | Buy | Maintains | $22 → $23 | +14.89% | Feb 18, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | +4.90% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
828.07M
from 775.76M
Increased by 6.74%
Revenue Next Year
900.84M
from 828.07M
Increased by 8.79%
EPS This Year
0.77
from 0.64
Increased by 19.53%
EPS Next Year
0.81
from 0.77
Increased by 5.33%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 928.6M | 1.0B | |||
| Avg | 828.1M | 900.8M | |||
| Low | 721.7M | 770.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 19.7% | 22.7% | |||
| Avg | 6.7% | 8.8% | |||
| Low | -7.0% | -6.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.88 | 0.86 | |
| Avg | 0.77 | 0.81 | |
| Low | 0.69 | 0.75 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 37.8% | 12.5% | |
| Avg | 19.5% | 5.3% | |
| Low | 7.2% | -1.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.